Delivery Order SPE2DB24D2215-SPE2DB25FGSNT
Award Date
3/7/25
Potential Completion Date
3/28/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. The contract, valued at $5,015.10, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract is a Delivery Order with a Firm Fixed Price...
The federal contract award is for the delivery of PROQUAD VIALS, a medical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,623.78, is a Delivery Order with a Firm Fixed Price pricing type. The award was made to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 21, 2025 and was awarded on December 27, 2024. The contract is not designated with...
This federal contract award is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $15,557.58 and an ultimate completion date of January 22, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price type and a potential ceiling value of $49,629.90. The contract has an ultimate completion date of March 17, 2025 and was awarded on February 24, 2025. There is no set-aside designation for this...
This federal contract award is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, through a Delivery Order contract valued at $1,570.54. It is a Firm Fixed Price contract with a performance period that runs through July 31, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for $91,552.80 on June 6, 2022. The contract has a completion date of June 28, 2022 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of PROQUAD VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,623.78, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is December 24, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award, valued at $12,537.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of PROQUAD VIALS, a medical product, with an ultimate completion date of October 2, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a ceiling value of $10,371.72 and is a firm fixed-price delivery order contract that runs through January 3, 2025. The contract was awarded on December 11, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a key...
This federal contract award is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $3,141.08, was awarded to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, on June 14, 2024. The contract is a Firm Fixed Price Delivery Order with a completion date of July 9, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds a...